原位植入港座与隧道式植入港座在乳腺癌化疗患者臂式输液港植入中的应用及其感染情况分析.pdf
《原位植入港座与隧道式植入港座在乳腺癌化疗患者臂式输液港植入中的应用及其感染情况分析.pdf》由会员分享,可在线阅读,更多相关《原位植入港座与隧道式植入港座在乳腺癌化疗患者臂式输液港植入中的应用及其感染情况分析.pdf(5页珍藏版)》请在咨信网上搜索。
1、中文科技期刊数据库(全文版)医药卫生 收稿日期:2023 年 12 月 21 日 作者简介:李斯维(1991),女,汉族,重庆人,本科,护士,研究方向为消化科。-31-原位植入港座与隧道式植入港座在乳腺癌化疗患者臂式输液港植入中的应用及其感染情况分析 李斯维 余 瑶 重庆大学附属江津医院消化科,重庆 402260 摘要:摘要:目的 探究原位植入港座与隧道式植入港座在乳腺癌化疗患者臂式输液港植入过程中应用情况及对感染发生率影响。方法 选择我院 2020 年 1 月至 2022 年 6 月期间乳腺癌化疗患者为研究对象,经纳入、排除标准筛选后,确认符合研究患者后,随机抽取 92 例乳腺癌化疗患者进入
2、研究,将其电脑随机分组分成 A 组、B 组,各 46例,两组患者在性别、年龄、化疗方案等一般资料比较差异无统计学意义(P0.05);在其臂式输液港植入过程中,A 组、B 组患者分别实施原位植入港座、隧道式植入港座,两组患者均持续随访至既定化疗方案结束,比较两组输液港植入疼痛程度、输液港植入后疼痛持续时间、化疗期间输液障碍发生率、并发症(囊袋周围血肿、药物外渗、感染、血栓等)发生率。结果 B 组植入后疼痛视觉模拟评分(VAS)为(3.430.65)分,较 A 组(2.860.55)分高,差异有统计学意义(t=4.540,P=0.0000.05);B 组疼痛持续时间为(4.240.48)d,与 A
3、 组(4.511.22)d 相近,差异无统计学意义(t=1.397,P=0.1660.05);B 组化疗期间输液障碍发生率为 8.70%(4/46),较 A 组 26.09%(12/46)低,差异有统计学意义(2=4.571,P=0.0330.05);B 组化疗期间,并发症发生率为 10.87%(5/46);A 组化疗期间,并发症发生率为 30.43%(14/46);B 组并发症发生率低于 A 组,差异有统计学意义(2=4.245,P=0.0390.05);B 组感染发生率均与 A 组相近,差异无统计学意义(2=0.261,P=0.6090.05)。结论 对乳腺癌化疗患者臂式输液港植入过程中,
4、与原位植入港座相比,采用隧道式植入港座,输液港置入后疼痛感受程度相对较高,但可降低输液障碍发生率及并发症发生率,效果显著。关键词:关键词:乳腺癌化疗;臂式输液港;隧道式植入港座 中图分类号:中图分类号:R73 Application and infection analysis of in-situ implantation port seat and tunnel implantation port seat in arm infusion port implantation for breast cancer patients undergoing chemotherapy LI Siwe
5、i YU Yao Department of Gastroenterology,Jiangjin Hospital,Chongqing University Chongqing 402260 Abstract:Objective To explore the application of in-situ implantation port seat and tunnel implantation port seat in the implantation process of arm infusion port for breast cancer patients undergoing che
6、motherapy and their influence on infection rate.Methods Patients with breast cancer chemotherapy in our hospital from January,2020 to June,2022 were selected as the research object.After screening by inclusion and exclusion criteria,92 patients with breast cancer chemotherapy were randomly selected
7、to enter the study,and they were randomly divided into group A and group B,with 46 patients in each group.There was no significant difference in general data such as gender,age and chemotherapy scheme between the two groups(P 0.05).During the implantation of the arm-type infusion port,patients in gr
8、oup A and 中文科技期刊数据库(全文版)医药卫生-32-group B were implanted into the port seat in situ and in tunnel respectively,and both groups were followed up until the end of the established chemotherapy scheme.The pain degree of the infusion port implantation,the pain duration after the infusion port implantation,
9、the incidence of infusion disorder and the incidence of complications(hematoma around the capsule,drug extravasation,infection,thrombosis,etc.)were compared between the two groups.Results The visual analogue scale(VAS)of pain in group B was(3.43 0.65),which was higher than that in group A(2.86 0.55)
10、,and the difference was statistically significant(t=4.540,P=0.000 0.05).The duration of pain in group B was(4.24 0.48)d,which was similar to that in group A(4.51 1.22)d,with no statistical significance(t=1.397,P=0.166 0.05).The incidence of transfusion disorder in group B was 8.70%(4/46),which was l
11、ower than that in group A(26.09%,12/46),with statistical significance(2=4.571,P=0.033 0.05).Among them,the second-grade infusion dysfunction in group B was 2.17%(1/46),which was lower than that in group A(17.39%(8/46),with statistical significance(2=4.434,P=0.035 0.05).The incidence of grade 3 trans
12、fusion dysfunction in group B was 6.52%(3/46),which was similar to that in group A(8.70%),and the difference was not statistically significant(2=0.000,P=1.000 0.05).There was no grade 4 transfusion dysfunction in both groups;During chemotherapy in group B,1 case(2.17%)had pericapsular hematoma,0 cas
13、e(0.00%)had drug extravasation,1 case(2.17%)had infection,1 case(2.17%)had thrombosis and 2 cases(4.35%)had subcutaneous congestion,and the incidence of complications was 10.87%(5/46).In group A,3 cases(6.52%)pericapsular hematoma,2 cases(4.36%)drug extravasation,3 cases(6.52%)infection,3 cases(6.52
14、%)thrombosis and 3 cases(6.52%)subcutaneous congestion occurred during chemotherapy,and the incidence of complications was 30.43%(14/46).The incidence of complications in group B was lower than that in group A,and the difference was statistically significant(2=4.245,P=0.039 0.05).The incidence of in
15、fection in group B was similar to that in group A,with no statistical significance(2=0.261,P=0.6090.05).Conclusion In the process of breast cancer chemotherapy patients arm infusion port implantation,compared with the in-situ implantation port seat,the tunnel implantation port seat has a higher degr
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- 原位 植入 隧道 乳腺癌 化疗 患者 输液 中的 应用 及其 感染 情况 分析
1、咨信平台为文档C2C交易模式,即用户上传的文档直接被用户下载,收益归上传人(含作者)所有;本站仅是提供信息存储空间和展示预览,仅对用户上传内容的表现方式做保护处理,对上载内容不做任何修改或编辑。所展示的作品文档包括内容和图片全部来源于网络用户和作者上传投稿,我们不确定上传用户享有完全著作权,根据《信息网络传播权保护条例》,如果侵犯了您的版权、权益或隐私,请联系我们,核实后会尽快下架及时删除,并可随时和客服了解处理情况,尊重保护知识产权我们共同努力。
2、文档的总页数、文档格式和文档大小以系统显示为准(内容中显示的页数不一定正确),网站客服只以系统显示的页数、文件格式、文档大小作为仲裁依据,平台无法对文档的真实性、完整性、权威性、准确性、专业性及其观点立场做任何保证或承诺,下载前须认真查看,确认无误后再购买,务必慎重购买;若有违法违纪将进行移交司法处理,若涉侵权平台将进行基本处罚并下架。
3、本站所有内容均由用户上传,付费前请自行鉴别,如您付费,意味着您已接受本站规则且自行承担风险,本站不进行额外附加服务,虚拟产品一经售出概不退款(未进行购买下载可退充值款),文档一经付费(服务费)、不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
4、如你看到网页展示的文档有www.zixin.com.cn水印,是因预览和防盗链等技术需要对页面进行转换压缩成图而已,我们并不对上传的文档进行任何编辑或修改,文档下载后都不会有水印标识(原文档上传前个别存留的除外),下载后原文更清晰;试题试卷类文档,如果标题没有明确说明有答案则都视为没有答案,请知晓;PPT和DOC文档可被视为“模板”,允许上传人保留章节、目录结构的情况下删减部份的内容;PDF文档不管是原文档转换或图片扫描而得,本站不作要求视为允许,下载前自行私信或留言给上传者【自信****多点】。
5、本文档所展示的图片、画像、字体、音乐的版权可能需版权方额外授权,请谨慎使用;网站提供的党政主题相关内容(国旗、国徽、党徽--等)目的在于配合国家政策宣传,仅限个人学习分享使用,禁止用于任何广告和商用目的。
6、文档遇到问题,请及时私信或留言给本站上传会员【自信****多点】,需本站解决可联系【 微信客服】、【 QQ客服】,若有其他问题请点击或扫码反馈【 服务填表】;文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“【 版权申诉】”(推荐),意见反馈和侵权处理邮箱:1219186828@qq.com;也可以拔打客服电话:4008-655-100;投诉/维权电话:4009-655-100。